Decision Making Publications/fr

Shrier I, Serner A, Wangensteen A, Steele RJ, Weir A. Measuring heterogeneity of reinjury risk assessments at the time of clearance to return to play: A feasibility study. J Sci Med Sport 2017 (In Press).
Shrier I. Strategic assessment of risk and risk tolerance (StARRT) framework for return to play decision making. Brit J Sports Med 49: 1311-1315 2015.
Shrier I, Safai, P, Charland L. Return-to-play following injury: Whose decision should it be? Br J Sport Med 48:394-401, 2014.
Shultz R, Bido J, Shrier I, Meeuwisse WH, Garza D, Matheson GO. Team clinician variability in return-to-play decisions. Clin J Sport Med 23:456-461, 2013.
Stovitz SD, Shrier I. Medical decision making and the importance of baseline risk. Brit J Gen Practice 63:795-797, 2013.
Matheson GO, Shultz R, Biddo J, Mitten MJ, Meeuwisse WM, Shrier I. Return to play decisions: are they the team physician’s responsibility? Clin J Sport Med 21(1): 25-30, 2011.
Klügl M, Shrier I, McBain K, Shultz R, Meeuwisse WH, Garza D, Matheson GO. The prevention of sport injury: An analysis of 12,000 published manuscripts. Clin J Sport Med 20(6): 407-412, 2010.
Creighton DW, Shrier I, Shultz R, Meeuwisse WH, Matheson GO. Return-to-play in sport: A decision-based model. Clin J Sport Med 20: 379-385, 2010.
Shrier I, Charland L, Mohtadi NGH, Meeuwisse WH, Matheson GO. The sociology of return-to-play decision making: a clinical perspective. Clin J Sport Med 20: 333-335, 2010.
Mazer B, Shrier I, Ehrmann Feldman D, Swaine B, Majnemar A, Kennedy E, Chilingaryan G.. Clinical management of musculoskeletal injuries in active children and youth. Clin J Sport Med 20: 249-255, 2010.
Shrier I. An approach to injuries in active people. Can Fam Phys 52: 727-731, 2006.
Shrier I. The usefulness of meta-analyses in treatment decisions. J Bone Joint Surg [Am] 83A: 1274-1275, 2001 (letter).

Publications de prise de décision

Contact

Solutions

A notre propos

Accueil

Retour au Bio du PDG

Shrier I, Serner A, Wangensteen A, Steele RJ, Weir A. Measuring heterogeneity of reinjury risk assessments at the time of clearance to return to play: A feasibility study. J Sci Med Sport 2017 (In Press).

Shrier I. Strategic assessment of risk and risk tolerance (StARRT) framework for return to play decision making. Brit J Sports Med 49: 1311-1315 2015.

Shrier I, Safai, P, Charland L. Return-to-play following injury: Whose decision should it be? Br J Sport Med 48:394-401, 2014.

Shultz R, Bido J, Shrier I, Meeuwisse WH, Garza D, Matheson GO. Team clinician variability in return-to-play decisions. Clin J Sport Med 23:456-461, 2013.

Stovitz SD, Shrier I. Medical decision making and the importance of baseline risk. Brit J Gen Practice 63:795-797, 2013.

Matheson GO, Shultz R, Biddo J, Mitten MJ, Meeuwisse WM, Shrier I. Return to play decisions: are they the team physician’s responsibility? Clin J Sport Med 21(1): 25-30, 2011.

Klügl M, Shrier I, McBain K, Shultz R, Meeuwisse WH, Garza D, Matheson GO. The prevention of sport injury: An analysis of 12,000 published manuscripts. Clin J Sport Med 20(6): 407-412, 2010.

Creighton DW, Shrier I, Shultz R, Meeuwisse WH, Matheson GO. Return-to-play in sport: A decision-based model. Clin J Sport Med 20: 379-385, 2010.

Shrier I, Charland L, Mohtadi NGH, Meeuwisse WH, Matheson GO. The sociology of return-to-play decision making: a clinical perspective. Clin J Sport Med 20: 333-335, 2010.

Mazer B, Shrier I, Ehrmann Feldman D, Swaine B, Majnemar A, Kennedy E, Chilingaryan G.. Clinical management of musculoskeletal injuries in active children and youth. Clin J Sport Med 20: 249-255, 2010.

Shrier I. An approach to injuries in active people. Can Fam Phys 52: 727-731, 2006.

Shrier I. The usefulness of meta-analyses in treatment decisions. J Bone Joint Surg [Am] 83A: 1274-1275, 2001 (letter).

Publications de prise de décision